Market Snapshot
S&P Futures
3,809.5
Dow Futures
30,868
Nasdaq Futures
11,633.25
Moderna, Inc. (MRNA) stock rallied over 0.03% intraday to trade at $142.85 a share on NASDAQ. The stock opened with a gain of 1.73% at $143.4 and touched an intraday high of $147.32, rising 0.03% against the last close of $142.81. The stock went to a low of $135.52 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-06-30 | $143.4 | $147.32 | $135.52 | $142.85 | 5,605,378 |
2022-06-29 | $140.425 | $144.36 | $138.618 | $142.81 | 2,908,100 |
2022-06-28 | $143.4 | $149.79 | $140.95 | $142.19 | 3,984,900 |
2022-06-27 | $143 | $146.4 | $138.49 | $145.36 | 4,392,800 |
2022-06-24 | $143.99 | $144.89 | $138.22 | $144.27 | 8,478,300 |
2022-06-23 | $136.04 | $143.66 | $132.8 | $143.26 | 4,721,200 |
2022-06-22 | $127.5 | $139.9 | $126.59 | $136.07 | 6,044,000 |
2022-06-21 | $130.495 | $134.575 | $129.67 | $129.99 | 4,321,400 |
2022-06-17 | $120.73 | $128.77 | $120.2 | $128.03 | 8,352,500 |
2022-06-16 | $124.38 | $125.255 | $118.06 | $121.08 | 5,720,000 |
Employees-
Beta1.65
Sales or Revenue18.47 Billion
5Y Sales Change179.40%
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryBiotechnology
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States and internationally. The company has 44 development programs, which includes 26 in clinical trials across seven modalities comprising prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic intracellular therapeutics, and inhaled pulmonary therapeutics. The company has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Moderna, Inc. (NASDAQ: MRNA) stock price is $142.85 as of the last check on Thursday, June 30. During the trading session, MRNA stock reached the peak price of $147.32 while $135.52 was the lowest point it dropped to.
The NASDAQ listed MRNA is part of Biotechnology industry that operates in the broader Health Care sector. Moderna, Inc. , a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States and internationally.
Colleen Hussey
Sr. Mang. of Corp. Communications
Dr. Noubar B. Afeyan Ph.D.
Co-Founder, Independent Non Exec. Chairman & Member of Technology Advisory Board
Mr. Stephane Bancel
CEO & Director
Dr. Stephen Hoge M.D.
Pres
MRNA stock traded closed the last session at $142.85, which is $0.04 or 0.03% lower than its previous close of $142.81. MRNA's current trading price is 23.56% lower than its 52-week high of $497.49 where as its distance from 52-week low of 115.61% is -71.29%.
Number of MRNA employees currently stands at -. MRNA operates from 200 Technology Square, Cambridge, MA 02139, United States.
Official Webiste of $MRNA is: https://www.modernatx.com
MRNA could be contacted at MRNA operates from 200 Technology Square, Cambridge, MA 02139, United States, or at phone #617 714 6500 and can also be accessed through its website.
MRNA stock volume for the day was 5,622,396 shares while in the previous session number of MRNA shares traded was 5,605,378 . The average number of MRNA shares traded daily for last 3 months was 5.97 Million.
The percentage change in MRNA stock occurred in the recent session was 0.03% while the dollar amount for the price change in MRNA stock was $0.04.
In the recent session, the day high for MRNA stock was $147.32 while the low for MRNA stock touched on the day was $135.52.
The market value of MRNA currently stands at 56.42 Billion with its latest stock price at $142.85 and 402 Million of its shares outstanding.